Chelsea Therapeutics International LTD (CHTP) financial statements (2023 and earlier)

Company profile

Business Address 3530 TORINGDON WAY
CHARLOTTE, NC 28277
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments45,32328,425
Cash and cash equivalents45,32328,425
Prepaid expense915
Prepaid expense and other current assets176
Other undisclosed current assets220175
Total current assets:46,45828,776
Noncurrent Assets
Property, plant and equipment45152
Total noncurrent assets:45152
TOTAL ASSETS:46,50328,928
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,9491,485
Accounts payable1,363788
Accrued liabilities372497
Employee-related liabilities213200
Total current liabilities:1,9491,485
Noncurrent Liabilities
Other undisclosed liabilities1,2981,526
Total liabilities:3,2473,011
Stockholders' equity
Stockholders' equity attributable to parent, including:43,25625,916
Common stock87
Additional paid in capital274,725240,971
Other undisclosed stockholders' equity attributable to parent(231,478)(215,061)
Total stockholders' equity:43,25625,916
TOTAL LIABILITIES AND EQUITY:46,50328,928

Income statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Operating expenses(16,434)(31,804)
Operating loss:(16,434)(31,804)
Nonoperating income
(Investment Income, Nonoperating)
1868
Net loss available to common stockholders, diluted:(16,416)(31,736)

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net loss:(16,416)(31,736)
Comprehensive loss, net of tax, attributable to parent:(16,416)(31,736)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: